SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...
Advances in genomics and RNA-based technologies are reshaping strategies for insect pest management by enabling the identification and exploitation of ...
Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a ...
The collaboration is currently centered on data gathering, quality control, and integration. Subsequent phases anticipate involving AI driven hypothesis generation, target ranking, and detailed ...
Pfizer collaboration applies Gordian’s large-scale in vivo mosaic screening platform to prioritize novel obesity targets directly within visceral adipose tissue Gordian Bio, a biotechnology company ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
PARIS, FRANCE, January 8, 2026 /EINPresswire.com/ — Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, today announced a ...
Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results